Location via proxy:   [ UP ]  
[Report a bug]   [Manage cookies]                

POBA Vs BMS

Download as ppt, pdf, or txt
Download as ppt, pdf, or txt
You are on page 1of 64

Interventional Conference

Bare Metal Stents


Basic Stent Design
Closed Cell
design

Modular Cell
design
High Pressure Inflation must balance
vessel injury vs. stent approximation
POBA vs BMS
> 3 mm

< 3 mm
No difference in
small vessels PTCA
vs. Stent
Non benefit for BMS in
small vessels
BMS in Acute MI
CABG vs. Stent
BMS in SVG
Saved
• Description
Stenting vs. PTCA for angiographic restenosis in vein grafts.

• Hypothesis
To compare stent implantation with balloon angioplasty for the treatment of obstructive disease of
venous bypass grafts.

• Drugs/Procedures Used
Palmaz-Schatz coronary stent vs balloon angioplasty

• Concomitant Medications

• Patients assigned to stent placement received aspirin (325 mg qd) and dipyridamole (75 mg tid),
beginning at least 24 hours before the procedure.

• During the procedure, patients received intravenous dextran 40 and heparin to maintain an
activated clotting time of more than 300 seconds. Warfarin therapy was begun on the day of the
procedure, and heparin therapy was continued until a therapeutic prothrombin time (international
normalized ratio, 2.0 to 3.5) was achieved.

• Dipyridamole and warfarin were continued for one month, and aspirin indefinitely.
Use of Covered stent
Covered Jo stent in SVG
DES vs. BMS

You might also like